Metals and Alzheimer's disease: how far have we come in the clinic?

Manuscript Number: 

17-0662R1

Author(s): 
Paul A. Adlard, Ashley I. Bush

Disclosures

Paul A. Adlard

  • Consulting Fees:
    I am a paid consultant for Prana Biotechnology and Armaron Bio.
    Equity:
    I am a shareholder in numerous publicly traded firms, but of relevance to this article is my minor shareholding in Prana Biotechnology.

Ashley I. Bush

  • Consulting Fees:
    Collaborative Medicinal Development Pty Ltd
    Equity:
    >$10,000 in Cogstate Ltd, Prana Biotechnology Ltd, Mesoblast Ltd